| Product NDC: | 57664-117 |
| Proprietary Name: | VERAPAMIL HYDROCHLORIDE |
| Non Proprietary Name: | VERAPAMIL HYDROCHLORIDE |
| Active Ingredient(s): | 180 mg/1 & nbsp; VERAPAMIL HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 57664-117 |
| Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090529 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120101 |
| Package NDC: | 57664-117-83 |
| Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (57664-117-83) |
| NDC Code | 57664-117-83 |
| Proprietary Name | VERAPAMIL HYDROCHLORIDE |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (57664-117-83) |
| Product NDC | 57664-117 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | VERAPAMIL HYDROCHLORIDE |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120101 |
| Marketing Category Name | ANDA |
| Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
| Substance Name | VERAPAMIL HYDROCHLORIDE |
| Strength Number | 180 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |